by Plus Therapeutics | Nov 8, 2024 | LM
You’re Invited to our symposium “Novel Targeted Radiotherapies to Manage Leptomeningeal Metastases,” presented at the Society for Neuro-Oncology Annual meeting in Houston. More information & RSVP: https://forms.gle/4WYXhAQzb7LHbpTm9 Don’t...
by Plus Therapeutics | Nov 6, 2024 | Uncategorized
BREAKING NEWS: Plus Therapeutics and SpectronRx Announce Radiotherapeutic Manufacturing Partnership Partnership will expand Plus’ capability to meet late-stage clinical and commercial forecasts for Rhenium (186Re) Obisbemeda and reinforce supply chain redundancy Press...
by Plus Therapeutics | Nov 4, 2024 | GBM
What a great glioblastoma patient summit hosted by @glioblastomaresearch🎗️🧠 We extend our heartfelt thanks to the organization for hosting this event, as well as to all the patients and caregivers who stopped by our booth and came to Dr. Brenner’s presentation...
by Plus Therapeutics | Nov 1, 2024 | GBM
Come by our booth this weekend at @glioblastomaresearch Glioblastoma Summit in Miami; also featuring a presentation by Dr. Andrew Brenner, MD, PhD on Saturday! Our clinical and patient advocacy team will be on-site to share educational material and answer your...
by Plus Therapeutics | Oct 30, 2024 | Uncategorized
Come join us at the upcoming @the_abta 5K run in New York City! It’s not too late to register as we join together in the fight against brain cancer. Plus Therapeutics is proud to be a sponsor and will have a booth on-site to provide education about our clinical...
Recent Comments